34289037|t|Emerging neurotropic features of SARS-CoV-2.
34289037|a|The prevailing coronavirus disease-19 (COVID-19) caused by a novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) has presented some neurological manifestations including hyposmia, hypogeusia, headache, stroke, encephalitis, Guillain-Barre syndrome, and some neuropsychiatric disorders. Although several cell types in the brain express angiotensin-converting enzyme-2 (ACE2), the main SARS-CoV-2 receptor, and other related proteins, it remains unclear whether the observed neurological manifestations are attributed to virus invasion into the brain or just comorbidities caused by dysregulation of systemic factors. Here, we briefly review the neurological manifestations of SARS-CoV-2, summarize recent evidence for the potential neurotropism of SARS-CoV-2, and discuss the potential mechanisms of COVID-19-associated neurological diseases.
34289037	33	43	SARS-CoV-2	Species	2697049
34289037	60	82	coronavirus disease-19	Disease	MESH:D000086382
34289037	84	92	COVID-19	Disease	MESH:D000086382
34289037	112	157	severe acute respiratory syndrome coronavirus	Species	694009
34289037	159	169	SARS-CoV-2	Species	2697049
34289037	228	236	hyposmia	Disease	MESH:D000086582
34289037	238	248	hypogeusia	Disease	MESH:D000370
34289037	250	258	headache	Disease	MESH:D006261
34289037	260	266	stroke	Disease	MESH:D020521
34289037	268	280	encephalitis	Disease	MESH:D004660
34289037	282	305	Guillain-Barre syndrome	Disease	MESH:D020275
34289037	316	342	neuropsychiatric disorders	Disease	MESH:D001523
34289037	393	424	angiotensin-converting enzyme-2	Gene	59272
34289037	426	430	ACE2	Gene	59272
34289037	733	743	SARS-CoV-2	Species	2697049
34289037	805	815	SARS-CoV-2	Species	2697049
34289037	857	865	COVID-19	Disease	MESH:D000086382
34289037	877	898	neurological diseases	Disease	MESH:D020271

